IQVIA Scribe vs RiSolve
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
IQVIA Scribe
This application allows patients participating in clinical trials to securely capture and submit data directly from their mobile devices. It provides relevant questionnaires throughout the study duration, amplifying patient voices in research.
- Online/offline data capture
- Patient enrollment notifications
- Study-specific questionnaires
- Secure data submission
- Automated eCOA process
Read full descriptionHide full description
IQVIA Scribe is an online/offline application used to capture data directly from patients enrolled in clinical trials. Patients enrolled in a study using Scribe will receive an enrollment notification via email or text with a link to download the application and instructions used to enroll in the study. Relevant questionnaires will be available for completion throughout the duration of the study ++++Scribe amplifies the patient's voice in clinical research by allowing Clinical Outcomes Assessments to be used in more trials. Whether deploying to smartphones, tablets or the web, our Sculptor visual build and deployment tools help automate the eCOA process, giving absolute transparency and greater control to sponsors and CRO’s.
RiSolve
Read full descriptionHide full description
RiSolve was developed in conjunction with world leading experts from the USA, Canada and Ireland. The content developed for RiSolve is based on knowledge from current scientific evidence. RiSolve is a well-rounded program that combines behavioral therapy and physiotherapy, bladder health education, nutritional guidance, and psychology to treat your overactive bladder. You can find Instructions for Use for RiSolve at www.risolvedtx.com/ifu. Please read the Instructions for Use for more information before you begin your treatment and throughout your treatment. To request a printed version of the IFU or for any additional queries, please contact us at support@risolvedtx.com. Disclaimer: Caution - Investigational Device. Limited by United States law to investigational use. RiSolve is not currently commercially approved anywhere in the world. It is not possible to use RiSolve without an invitation code. Privacy Policy: https://www.risolvedtxdashboard.com/resources/privacypolicy Terms and Conditions: https://www.risolvedtxdashboard.com/resources/termsandconditions
Screenshots
Verdict
The clearest difference is update cadence: RiSolve at monthly against IQVIA Scribe's every 2 months. On price, ads, in-app purchases and device support there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
IQVIA Scribe ships an update every 2 months, RiSolve monthly. The most recent releases landed on October 20, 2026 and October 10, 2026 respectively.
| Parameter | IQVIA Scribe | RiSolve |
|---|---|---|
| Price | Free | Free |
| Rating | 3.0 (37 ratings) — better | — |
| Positive reviews | 20.0% of reviews | — |
| Number of ratings | 37 — better | — |
| Update frequency | Every 2 months | Monthly — better |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | — |
| Devices | iPhone, iPad, iPod — better | iPhone, iPad |
| Requires iOS | 15.5 | 15.0 — better |
| Further details — not scored | ||
| Size | 33 MB | 171 MB |
| Age rating | 4+ | 17+ |
| Developer | IQVIA RDS INC. | Amara Therapeutics Limited |
In-app purchases
IQVIA Scribe
No in-app purchases
RiSolve
No in-app purchases
